| Autor: |
Peronard R; Department of Cardiology, Herlev-Gentofte University Hospital, Copenhagen, Denmark., Mayntz S; Cardiology Research Unit, Odense University Hospital, Svendborg, Denmark. Stephan.mayntz@gmail.com.; Department of Clinical Research, University of Southern Denmark, Odense, Denmark. Stephan.mayntz@gmail.com. |
| Jazyk: |
angličtina |
| Zdroj: |
American journal of cardiovascular drugs : drugs, devices, and other interventions [Am J Cardiovasc Drugs] 2024 Dec 16. Date of Electronic Publication: 2024 Dec 16. |
| DOI: |
10.1007/s40256-024-00706-9 |
| Abstrakt: |
Competing Interests: Declarations. Funding: No external funding was used in the preparation of this letter. Conflict of interest: Rose Peronard and Stephan Mayntz declare that they have no potential conflicts of interest that might be relevant to the contents of this manuscript. Author contributions: CRediT S.M. carried out study conceptualization, writing—original draft, and writing—review and editing; R,.P. carried out writing—review and editing. Data availability: Data sharing not applicable to this article as no datasets were generated for this letter. Ethics approval: Not Applicable. Code availability: Not Applicable. Consent to participate: Not Applicable. Consent for publication: Not Applicable. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
Full text from SpringerLink